- SOX Antibodies in Small-Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome: Frequency and Relation With Survival
[作者：Titulaer, MJ; Klooster, R; Potman, M; Sabater, L; Graus, F; Hegeman, IM; Thijssen, PE; Wirtz, PW; Twijnstra, A; Smitt, PAES; van der Maarel, SM; Verschuuren, JJGM,期刊：Journal of clinical oncology, 页码：4260-4267 , 文章类型： Proceedings Paper，,卷期：2009年27-26]
- Purpose SOX1 antibodies are common in small-cell lung carcinoma (SCLC) with and without paraneoplastic syndrome (PNS) and can serve as serological tumor marker. Addition of other antibodies might improve its diagnostic p...
- Quality-Adjusted Time Without Symptoms or Toxicity Analysis of Adjuvant Chemotherapy in Non-Small-Cell Lung Cancer: An Analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial
[作者：Jang, RW; Le Maitre, A; Ding, KY; Winton, T; Bezjak, A; Seymour, L; Shepherd, FA; Leighl, NB,期刊：Journal of clinical oncology, 页码：4268-4273 , 文章类型： Proceedings Paper，,卷期：2009年27-26]
- Purpose National Cancer Institute of Canada Clinical Trials Group JBR.10 demonstrated that adjuvant vinorelbine and cisplatin after resection of stage IB-II non-small-cell lung cancer (NSCLC) improved relapse-free and ov...
- Phase II, Multicenter, Uncontrolled Trial of Single-Agent Sorafenib in Patients With Relapsed or Refractory, Advanced Non-Small-Cell Lung Cancer
[作者：Blumenschein, GR; Gatzemeier, U; Fossella, F; Stewart, DJ; Cupit, L; Cihon, F; O'Leary, J; Reck, M,期刊：Journal of clinical oncology, 页码：4274-4280 , 文章类型： Proceedings Paper，,卷期：2009年27-26]
- Purpose Sorafenib is an oral multikinase inhibitor that targets the Ras/Raf/MEK/ERK mitogenic signaling pathway and the angiogenic receptor tyrosine kinases, vascular endothelial growth factor receptor 2 and platelet-der...
- Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03
[作者：Le, QT; Harris, J; Magliocco, AM; Kong, CS; Diaz, R; Shin, B; Cao, HB; Trotti, A; Erler, JT; Chung, CH; Dicker, A; Pajak, TF; Giaccia, AJ; Ang, KK,期刊：Journal of clinical oncology, 页码：4281-4286 , 文章类型： Article，,卷期：2009年27-26]
- Purpose To validate lysyl oxidase (LOX), a hypoxia-related protein, as a marker for metastasis in an independent head and neck cancer (HNC) patient group enrolled onto a prospective trial. Patients and Methods We perform...
- Evaluation of Microtubule-Associated Protein-Tau Expression As a Prognostic and Predictive Marker in the NSABP-B 28 Randomized Clinical Trial
[作者：Pusztai, L; Jeong, JH; Gong, Y; Ross, JS; Kim, C; Paik, S; Rouzier, R; Andre, F; Hortobagyi, GN; Wolmark, N; Symmans, WF,期刊：Journal of clinical oncology, 页码：4287-4292 , 文章类型： Article，,卷期：2009年27-26]
- Purpose We assessed Tau protein expression in primary breast cancer specimens of patients included in the National Surgical Breast and Bowel Project (NSABP)-B 28 clinical trial. Expression levels were correlated with dis...
- Chromogranin-A and N-Terminal Pro-Brain Natriuretic Peptide: An Excellent Pair of Biomarkers for Diagnostics in Patients With Neuroendocrine Tumor
[作者：Korse, CM; Taal, BG; de Groot, CA; Bakker, RH; Bonfrer, JMG,期刊：Journal of clinical oncology, 页码：4293-4299 , 文章类型： Article，,卷期：2009年27-26]
- Purpose For the last decade chromogranin-A (CgA) has been a well-established marker for neuroendocrine tumor (NET), and N-terminal pro-brain natriuretic peptide (NT-proBNP) has been a useful marker for left ventricular d...
- Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era
[作者：Stephenson, AJ; Kattan, MW; Eastham, JA; Bianco, FJ; Yossepowitch, O; Vickers, AJ; Klein, EA; Wood, DP; Scardino, PT,期刊：Journal of clinical oncology, 页码：4300-4305 , 文章类型： Article，,卷期：2009年27-26]
- Purpose The long-term risk of prostate cancer-specific mortality (PCSM) after radical prostatectomy is poorly defined for patients treated in the era of widespread prostate-specific antigen (PSA) screening. Models that p...
- Risk Assessment Among Prostate Cancer Patients Receiving Primary Androgen Deprivation Therapy
[作者：Cooperberg, MR; Hinotsu, S; Namiki, M; Ito, K; Broering, J; Carroll, PR; Akaza, H,期刊：Journal of clinical oncology, 页码：4306-4313 , 文章类型： Proceedings Paper，,卷期：2009年27-26]
- Purpose Prostate cancer epidemiology has been marked overall by a downward risk migration over time. However, in some populations, both in the United States and abroad, many men are still diagnosed with high-risk and/or ...
- Prospective Study of [F-18]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Staging of Muscle-Invasive Bladder Carcinoma
[作者：Kibel, AS; Dehdashti, F; Katz, MD; Klim, AP; Grubb, RL; Humphrey, PA; Siegel, C; Cao, DF; Gao, F; Siegel, BA,期刊：Journal of clinical oncology, 页码：4314-4320 , 文章类型： Article，,卷期：2009年27-26]
- Purpose Novel imaging modalities are needed to detect occult metastatic disease in bladder carcinoma. Patients with regional lymphatic spread could be targeted for neoadjuvant chemotherapy, and patients with distant meta...
- Quality of Surveillance for Stage I Testis Cancer in the Community
[作者：Yu, HY; Madison, RA; Setodji, CM; Saigal, CS,期刊：Journal of clinical oncology, 页码：4327-4332 , 文章类型： Proceedings Paper，,卷期：2009年27-26]
- Purpose Patients with clinical stage I testicular germ cell tumors have been managed with adjuvant radiotherapy, chemotherapy, or retroperitoneal lymph node dissection (RPLND). The use of surveillance-only strategies at ...
- Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Recombinant Human Intestinal Trefoil Factor Oral Spray for Prevention of Oral Mucositis in Patients With Colorectal Cancer Who Are Receiving Fluorouracil-Based Chemotherapy
[作者：Peterson, DE; Barker, NP; Akhmadullina, LI; Rodionova, I; Sherman, NZ; Davidenko, IS; Rakovskaya, GN; Gotovkin, EA; Shinkarev, SA; Kopp, MV; Kulikov, EP; Moiseyenko, VM; Gertner, JM; Firsov, I; Tuleneva, T; Yarosh, A; Woon, CW,期刊：Journal of clinical oncology, 页码：4333-4338 , 文章类型： Proceedings Paper，,卷期：2009年27-26]
- Purpose This study evaluated the safety and efficacy of recombinant human intestinal trefoil factor (rhITF) administered as topical oral spray for prevention and treatment of chemotherapy-induced oral mucositis (OM). Pat...
- Predictive Capacity of Three Comorbidity Indices in Estimating Mortality After Surgery for Colon Cancer
[作者：Hines, RB; Chatla, C; Bumpers, HL; Waterbor, JW; McGwin, G; Funkhouser, E; Coffey, CS; Posey, J; Manne, U,期刊：Journal of clinical oncology, 页码：4339-4345 , 文章类型： Article，,卷期：2009年27-26]
- Purpose Although, for patients with cancer, comorbidity can affect the timing of cancer detection, treatment, and prognosis, there is little information relating to the question of whether the choice of comorbidity index...
- Distress in Older Patients With Cancer
[作者：Hurria, A; Li, DN; Hansen, K; Patil, S; Gupta, R; Nelson, C; Lichtman, SM; Tew, WP; Hamlin, P; Zuckerman, E; Gardes, J; Limaye, S; Lachs, M; Kelly, E,期刊：Journal of clinical oncology, 页码：4346-4351 , 文章类型： Article，,卷期：2009年27-26]
- Purpose To determine the predictors of distress in older patients with cancer. Patients and Methods Patients age >= 65 years with a solid tumor or lymphoma completed a questionnaire that addressed these geriatric assessm...
- Prognostic Implications of NOTCH1 and FBXW7 Mutations in Adults With T-Cell Acute Lymphoblastic Leukemia Treated on the MRC UKALLXII/ECOG E2993 Protocol
[作者：Mansour, MR; Sulis, ML; Duke, V; Foroni, L; Jenkinson, S; Koo, K; Allen, CG; Gale, RE; Buck, G; Richards, S; Paietta, E; Rowe, JM; Tallman, MS; Goldstone, AH; Ferrando, AA; Linch, DC,期刊：Journal of clinical oncology, 页码：4352-4356 , 文章类型： Article，,卷期：2009年27-26]
- Purpose Notch pathway activation by mutations in either NOTCH1 and/or FBXW7 is one of the most common molecular events in T-cell acute lymphoblastic leukemia (T-ALL) and, in pediatric disease, predicts for favorable outc...
|